ClinicalTrials.gg
Not yet recruitingNCT06310044Updated Mar 13, 2024

Effect of Commiphora Myrrh Solution as a Root Canal Irrigant on Post Operative Pain and Bacterial Load Reduction in Necrotic Tooth

An interventional study of Root canal irrigant Commiphora Myrrh 50% in Necrotic Pulp, sponsored by Cairo University. Not yet recruiting. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-13.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 37 studies in Dental Pulp Necrosis by Cairo University — 5 open to participants now, 5 under way, none of them phase 3. Dental Pulp Necrosis · Cairo University.

Planned enrollment
18th of 37
42 · median 42
Started
2024
with 1 other
No phase
27 of 37
3 open now
Registered
34th of 37
by date

Among the 37 studies in Dental Pulp Necrosis by Cairo University, this one is the 18th largest by planned enrollment, is one of 2 that started in 2024, is one of 27 with no phase, and was the 34th registered.

Dental Pulp Necrosis

157 studies on the registry are indexed under Dental Pulp Necrosis; 44 are open to participants now.

Browse Dental Pulp Necrosis studies →

Open to participants now

5 of the 37 studies in Dental Pulp Necrosis by Cairo University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 15 Dental Pulp Necrosis studies recruiting now, 6 (40%) set no upper age limit and 7 (47%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.

This study: 20 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Dental Pulp Necrosis by Cairo University, or all of them as a file.
02

Study summary

Clinically compare the post-operative pain , incidences post-operative swelling , post-operative number of analgesic tablets taken by patient and amount of bacterial load reduction after using 50% Commiphora Myrrh Chemomechanical preparation , versus 2.5% NaOCl,in asymptomatic necrotic mandibular premolar treated in single visit.

Read the detailed description

The patients will be randomly divided into 2 groups. Intervention group (50% Commiphora Myrrh solution root canal irrigant) and control group (2.5% sodium hypochlorite root canal irrigant)

Post-operative pain will be measured at 6,12,24,48 hours post-operatively The pain will be recorded using numerical rating scale

Post-operative swelling will be measured at 6,12,24,48 hours post-operatively The swelling will be receded using visual swelling rating scale

Number of analgesic tablets taken by the patient post-operatively. Up to 48 hours

Amount of bacteria load reduction The intracanal bacterial load reduction will be determined using agar culture technique by counting the colony forming units per milliliter (CFI /ml) before and after root canal preparation.

03

Conditions studied

  • Necrotic Pulp

Browse trials for

Keywords

  • Asymptomatic Necrotic Mandibular Premolar
04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Systemically healthy patient (, II).
  2. Age between 20 and 40 years.
  3. Male or female.
  4. Patient who is able to sign and comprehend the pain scale (committed patient).
  5. Mandibular single rooted premolars having the following criteria:

    • With single root canal.
    • Diagnosed clinically with pulp necrosis.
    • Absence of spontaneous pulpal pain.
    • Positive pain on percussion denoting apical periodontitis.
    • Slight widening of periodontal space or peri-apical radiolucency smaller than 3 mm (0-2mm)

Exclusion criteria

Exclusion Criteria:

  1. Medically compromised patients ().
  2. Teeth with:
  3. Patients who could not interpret the NRS.

    • Immature roots.
    • Vital pulp tissues.
    • Association with swelling.
    • Acute peri-apical abscess or acute exacerbation of a chronic abscess.
    • Mobility Grade II or III.
    • Previously accessed or endodontically treated.
    • Deep periodontal pockets more than 4 mm.
    • Vertical root fractures, coronal perforation, calcification, and external or internal root resorptions.
  4. Patients with diabetes, immune-compromising, and disease and pregnant women will be also excluded.
  5. History of intolerance to NSAIDs.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
42 participants (estimated)

Study arms

  • Experimental
    Commiphora Myrrh

    50% Commiphora Myrrh

    Other: Root canal irrigant Commiphora Myrrh 50%

  • Active comparator
    Sodium hypochlorite

    2.5% NaOCl

    Other: Root canal irrigant Commiphora Myrrh 50%

Interventions

  • OtherRoot canal irrigant Commiphora Myrrh 50%

    Root canal irrigant

06

What researchers measure

Primary outcomes

  1. Post-operative pain

    Categorical None 0 Mild 1-3 Moderate 4-6 Sever 7-10

    Time frame: Post-operative pain measured at 6,12,24,48 hours after single visit Treatment

Secondary outcomes

  1. incidence of Post-operative swelling

    Categorical Of visual swelling scale of post- operative

    Time frame: Up to 48 hours post-

Other outcomes

  1. Amount of intracanal Bacterial CFUs/ml

    Intra canal bacterial load reduction will be determined using agar culture technique by counting the colony forming units per milliliter (CFUs/ml) before and after root canal preparation

    Time frame: Pre-intervention, pre-instrumentation after access cavity. Post-instrumentation up to 10min

  2. Number of analgesic Counting Tablets taken by the patient after endodontic treatment

    Counting the tablet after the treatment

    Time frame: Up to 48hours post-operative

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2024; primary completion for Jan 2025, 8 months later.

Of 66 non-industry interventional studies with no phase under Dental Pulp Necrosis, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 35. This study's planned 8 months is below that.

Counting every sponsor, half of 67 studies reached it within 15 months; a quarter within 9 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2024
First posted
Mar 13, 2024
StartEst.
May 1, 2024
Primary completionEst.
Jan 1, 2025
CompletionEst.
Jan 1, 2025
Last update
Mar 13, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06310044
Lead sponsor
Cairo University
Responsible party
Rahaf Abdullah khalel manzalawi (Principal investigator, Cairo University) — Principal investigator
First posted
Mar 13, 2024
Start date
May 1, 2024 (estimated)
Primary completion
Jan 1, 2025 (estimated)
Completion
Jan 1, 2025 (estimated)
Last update
Mar 13, 2024

Study contacts

Rahaf A Manzalawi, BDS
Contact
rahaf.manzlawi@dentistry.cu.edu.eg
01150019478 ext. +20

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion